Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 1067

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 1067
---
 thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-factand agent full power and authority to do and perform each and every act and thing necessary or appropriate to be done with respect to this registration statement or any amendments hereto in the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-factand agent, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue thereof. Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities indicated:

| SIGNATURE                                                               
 /s/ James A. Bianco, M.D. James A. Bianco, M.D. Chief Executive Officer 
 /s/ Dan Dearborn Dan Dearborn Chief Financial Officer                   |     | TITLE                                
 Chief Executive Officer and Director 
 Chief Financial Officer              |     | DATE             
 February 7, 2025 
 February 7, 2025 |
|:------------------------------------------------------------------------|:----|:-------------------------------------|:----|:-----------------|
| /s/ James Manuso, Ph.D James Manuso, Ph.D.                              |     | Director                             |     | February 7, 2025 |
| /s/ Alan List, M.D. Alan List, M.D.                                     |     | Director                             |     | February 7, 2025 |
| /s/ George Ng George Ng                                                 |     | Director                             |     | February 7, 2025 |
| /s/ Robert Hoffman Robert Hoffman                                       |     | Director                             |     | February 7, 2025 |

II-8